title: Changes in serum levels of growth factors in healthy individuals after living related liver donation.
abstract: BACKGROUND
  To obtain better insight into the kinetics of hepatic growth factors following partial hepatectomy for living related liver donation, we investigated the postoperative changes in serum levels of hepatocyte growth factor (HGF), epidermal growth factor (EGF), vascular epidermal growth factor (VEGF), and transforming growth factor-alpha (TGF-alpha).
  
  
  METHODS
  Eighteen healthy donors undergoing right hepatectomy for living related donation were enrolled in this study. Serum levels of HGF, EGF, VEGF, and TGF-alpha were measured using enzyme-linked immunosorbent assay kits before surgery, at 2 hours after resection, and daily during 5 days postoperatively.
  
  
  RESULTS
  Mean preoperative HGF serum levels in healthy adults were 778 +/- 64 pg/mL. Within 2 hours after operation, they significantly increased to 9608 +/- 3111 pg/mL afterward decreasing to 2726 +/- 241 at day 1 and 2283 +/- 250 pg/mL at day 2. Hereafter HGF serum levels stabilized at increased levels until day 5 (2109 +/- 138, 2047 +/- 219, 2283 +/- 336 pg/mL, respectively). At all time points, the differences between pre- and postoperative HGF levels were significant (P < .01). In contrast, VEGF and EGF serum levels showed no significant differences between pre- and postoperative levels at all time points. TGF-alpha was not detected using a commercially available test with a detection limit of 10 ng/mL, suggesting only low TGF-alpha serum levels following liver resection.
  
  
  CONCLUSIONS
  Significantly increased HGF serum levels after hepatectomy demonstrate its crucial role among the other investigated growth factors in regeneration of the remnant liver tissue during the early period after the operation.
authors.affiliation: Department of General-, Visceral- and Transplantation Surgery, Charité, Campus Virchow Clinic, University Medicine, Berlin, Germany. ekaterina.efimova@charite.de
authors.forename: E A
authors.initials: EA
authors.lastname: Efimova
authors.forename: M
authors.initials: M
authors.lastname: Glanemann
authors.forename: A K
authors.initials: AK
authors.lastname: Nussler
authors.forename: G
authors.initials: G
authors.lastname: Schumacher
authors.forename: U
authors.initials: U
authors.lastname: Settmacher
authors.forename: S
authors.initials: S
authors.lastname: Jonas
authors.forename: N
authors.initials: N
authors.lastname: Nussler
authors.forename: P
authors.initials: P
authors.lastname: Neuhaus
mesh_terms: D004815:Epidermal Growth Factor / Q000097:blood; D006133:Growth Substances / Q000097:blood*; D006498:Hepatectomy; D017228:Hepatocyte Growth Factor / Q000097:blood; D006801:Humans; D008099:Liver; D019520:Living Donors; D011184:Postoperative Period; D012016:Reference Values; D020858:Tissue and Organ Harvesting; D016211:Transforming Growth Factor alpha / Q000097:blood; D042461:Vascular Endothelial Growth Factor A / Q000097:blood
chemical_list: D006133:Growth Substances; D016211:Transforming Growth Factor alpha; D042461:Vascular Endothelial Growth Factor A; D004815:Epidermal Growth Factor; D017228:Hepatocyte Growth Factor